Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Cash from Operations (2023 - 2025)

Mangoceuticals' Cash from Operations history spans 3 years, with the latest figure at 1241264.0 for Q3 2025.

  • For Q3 2025, Cash from Operations fell 6.47% year-over-year to 1241264.0; the TTM value through Sep 2025 reached 5902069.0, down 8.65%, while the annual FY2024 figure was 4863776.0, 30.49% up from the prior year.
  • Cash from Operations for Q3 2025 was 1241264.0 at Mangoceuticals, up from 1256449.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 991131.0 in Q1 2024 and bottomed at 2274781.0 in Q1 2025.
  • The 3-year median for Cash from Operations is 1577236.0 (2024), against an average of 1512149.55.
  • The largest annual shift saw Cash from Operations surged 45.19% in 2024 before it tumbled 129.51% in 2025.
  • A 3-year view of Cash from Operations shows it stood at 1697741.0 in 2023, then soared by 33.47% to 1129575.0 in 2024, then dropped by 9.89% to 1241264.0 in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Cash from Operations are 1241264.0 (Q3 2025), 1256449.0 (Q2 2025), and 2274781.0 (Q1 2025).